It remains unclear why some obese patients with NAFLD have only steatosis whereas others exhibit steatohepatitis, and alcohol consumption could have a different effect in these two conditions.

Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive ...

The trials identified no serious adverse effects, and patients tolerated a daily dosage of 1500 mg for 24 weeks.